BOC Sciences
About BOC Sciences
Categories
-
Country/Region:United States
-
On CPHI since:2022
-
Employees:250 - 499
Company types
Primary activities
Products from BOC Sciences (3)
-
Product (-)-Blebbistatin
(-)-Blebbistatin is a cell-permeable inhibitor for non muscle myosin II ATPase with IC50 of ~2 μM, does not inhibit myosin light chain kinase, inhibits contraction of the cleavage furrow without disrupting mitosis or contractile ring assembly.
-
Product N1-MethylpseudoUridine-5'-Triphosphate
N1-MethylpseudoUridine-5'-Triphosphate is a modified NTP for incorporation into messenger RNAs (mRNA) using T7 RNA Polymerase. Incorporation of N1-methylpseudouridine can reduce the immunogenicity of the resulting mRNA. The sodium form N1-MethylpseudoUridine-5'-Triphosphate Sodium (B2706-358101) is in stoc... -
Product Polyquaternium 1
Polyquaternium 1 is an ophthalmic preservative.
BOC Sciences Resources (2)
-
News Prof. Gang Zheng to Share Insights on Theranostic Lipid Nanoparticles in Exclusive BOC Sciences Webinar
BOC Sciences hosts Prof. Gang Zheng in a groundbreaking webinar on theranostic lipid nanoparticles for cancer medicine. -
Industry Webinar Webinar: Vascular Nano-Delivery Using Tropism and Targeting
December 12th, 2025 10:00 EST
In this session, Dr. Vladimir Muzykantov will present an in-depth analysis of the current advances and challenges in drug targeting, biomaterials, nanomedicine, drug delivery systems (DDS), intracellular delivery, and biotherapeutics (Bios).
Free registration at https://www.bocsci.com/delivery-nanocarriers-to-desirable-vascular-destinations-fortuitous-tropism-vs-cognizant-targeting.html